These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29996896)

  • 1. Adipocyte-specific Repression of PPAR-gamma by NCoR Contributes to Scleroderma Skin Fibrosis.
    Korman B; Marangoni RG; Lord G; Olefsky J; Tourtellotte W; Varga J
    Arthritis Res Ther; 2018 Jul; 20(1):145. PubMed ID: 29996896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPARγ downregulation by TGFß in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesis.
    Wei J; Ghosh AK; Sargent JL; Komura K; Wu M; Huang QQ; Jain M; Whitfield ML; Feghali-Bostwick C; Varga J
    PLoS One; 2010 Nov; 5(11):e13778. PubMed ID: 21072170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A synthetic PPAR-γ agonist triterpenoid ameliorates experimental fibrosis: PPAR-γ-independent suppression of fibrotic responses.
    Wei J; Zhu H; Komura K; Lord G; Tomcik M; Wang W; Doniparthi S; Tamaki Z; Hinchcliff M; Distler JH; Varga J
    Ann Rheum Dis; 2014 Feb; 73(2):446-54. PubMed ID: 23515440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: potential utility as biomarker?
    Lakota K; Wei J; Carns M; Hinchcliff M; Lee J; Whitfield ML; Sodin-Semrl S; Varga J
    Arthritis Res Ther; 2012 May; 14(3):R102. PubMed ID: 22548780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy.
    Fang F; Liu L; Yang Y; Tamaki Z; Wei J; Marangoni RG; Bhattacharyya S; Summer RS; Ye B; Varga J
    Arthritis Res Ther; 2012 Oct; 14(5):R229. PubMed ID: 23092446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipocyte NCoR knockout decreases PPARγ phosphorylation and enhances PPARγ activity and insulin sensitivity.
    Li P; Fan W; Xu J; Lu M; Yamamoto H; Auwerx J; Sears DD; Talukdar S; Oh D; Chen A; Bandyopadhyay G; Scadeng M; Ofrecio JM; Nalbandian S; Olefsky JM
    Cell; 2011 Nov; 147(4):815-26. PubMed ID: 22078880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta.
    McCoy SS; Reed TJ; Berthier CC; Tsou PS; Liu J; Gudjonsson JE; Khanna D; Kahlenberg JM
    Rheumatology (Oxford); 2017 Nov; 56(11):1970-1981. PubMed ID: 28968684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The optimal corepressor function of nuclear receptor corepressor (NCoR) for peroxisome proliferator-activated receptor γ requires G protein pathway suppressor 2.
    Guo C; Li Y; Gow CH; Wong M; Zha J; Yan C; Liu H; Wang Y; Burris TP; Zhang J
    J Biol Chem; 2015 Feb; 290(6):3666-79. PubMed ID: 25519902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of small ubiquitin-like modifier-1, nuclear receptor coreceptor, histone deacetylase 3, and peroxisome proliferator-activated receptor-γ in human adipose tissue.
    Finlin BS; Bodles-Brakhop AM; Yao-Borengasser A; Zhu B; Starnes CP; McGehee RE; Peterson CA; Kern PA; Rasouli N
    Metab Syndr Relat Disord; 2012 Aug; 10(4):312-7. PubMed ID: 22651256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma.
    Wu M; Melichian DS; Chang E; Warner-Blankenship M; Ghosh AK; Varga J
    Am J Pathol; 2009 Feb; 174(2):519-33. PubMed ID: 19147827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrosis in systemic sclerosis: emerging concepts and implications for targeted therapy.
    Wei J; Bhattacharyya S; Tourtellotte WG; Varga J
    Autoimmun Rev; 2011 Mar; 10(5):267-75. PubMed ID: 20863909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-130b regulates scleroderma fibrosis by targeting peroxisome proliferator-activated receptor γ.
    Luo H; Zhu H; Zhou B; Xiao X; Zuo X
    Mod Rheumatol; 2015 Jul; 25(4):595-602. PubMed ID: 25547017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
    Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
    Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosis.
    Ruzehaji N; Frantz C; Ponsoye M; Avouac J; Pezet S; Guilbert T; Luccarini JM; Broqua P; Junien JL; Allanore Y
    Ann Rheum Dis; 2016 Dec; 75(12):2175-2183. PubMed ID: 26961294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nuclear receptor corepressors NCoR and SMRT decrease peroxisome proliferator-activated receptor gamma transcriptional activity and repress 3T3-L1 adipogenesis.
    Yu C; Markan K; Temple KA; Deplewski D; Brady MJ; Cohen RN
    J Biol Chem; 2005 Apr; 280(14):13600-5. PubMed ID: 15691842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic Toll-like receptor 4 stimulation in skin induces inflammation, macrophage activation, transforming growth factor beta signature gene expression, and fibrosis.
    Stifano G; Affandi AJ; Mathes AL; Rice LM; Nakerakanti S; Nazari B; Lee J; Christmann RB; Lafyatis R
    Arthritis Res Ther; 2014 Jul; 16(4):R136. PubMed ID: 24984848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor delta-mediated transactivation.
    Krogsdam AM; Nielsen CA; Neve S; Holst D; Helledie T; Thomsen B; Bendixen C; Mandrup S; Kristiansen K
    Biochem J; 2002 Apr; 363(Pt 1):157-65. PubMed ID: 11903058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
    Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH
    Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of latent TGF-β-binding protein 4 affects the fibrotic process in scleroderma by TGF-β/SMAD signaling.
    Lu J; Liu Q; Wang L; Tu W; Chu H; Ding W; Jiang S; Ma Y; Shi X; Pu W; Zhou X; Jin L; Wang J; Wu W
    Lab Invest; 2017 May; 97(5):591-601. PubMed ID: 28263294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of peroxisome proliferator-activated receptor gamma in mouse fibroblasts results in increased susceptibility to bleomycin-induced skin fibrosis.
    Kapoor M; McCann M; Liu S; Huh K; Denton CP; Abraham DJ; Leask A
    Arthritis Rheum; 2009 Sep; 60(9):2822-9. PubMed ID: 19714649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.